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Background: Graphical probabilistic models have the ability to provide insights as to how 
clinical factors are conditionally related. These models can be used to help us understand fac-
tors influencing health care outcomes and resource utilization, and to estimate morbidity and 
clinical outcomes in trauma patient populations.
Study design: Thirty-two combat casualties with severe extremity injuries enrolled in a pro-
spective observational study were analyzed using step-wise machine-learned Bayesian belief 
network (BBN) and step-wise logistic regression (LR). Models were evaluated using 10-fold 
cross-validation to calculate area-under-the-curve (AUC) from receiver operating characteristics 
(ROC) curves.
Results: Our BBN showed important associations between various factors in our data set that 
could not be developed using standard regression methods. Cross-validated ROC curve analysis 
showed that our BBN model was a robust representation of our data domain and that LR models 
trained on these findings were also robust: hospital-acquired infection (AUC: LR, 0.81; BBN, 
0.79), intensive care unit length of stay (AUC: LR, 0.97; BBN, 0.81), and wound healing (AUC: 
LR, 0.91; BBN, 0.72) showed strong AUC.
Conclusions: A BBN model can effectively represent clinical outcomes and biomarkers in 
patients hospitalized after severe wounding, and is confirmed by 10-fold   cross-validation and 
further confirmed through logistic regression modeling. The method warrants further develop-
ment and independent validation in other, more diverse patient populations.
Keywords: combat, wounds, probabilistic model, Bayesian belief network, outcomes
Introduction
Blast-related injuries predominate on the modern day battlefields in Iraq and 
  Afghanistan. Improvised bombs and rocket attacks inflict devastating injuries on both 
civilians and military personnel.1–3 Frequency and severity notwithstanding, more 
military personnel are surviving these attacks due to a number of advances in care and 
body protection, albeit with a marked change in the type of injuries most commonly 
sustained. The development and widespread utilization of effective personal body armor 
has further shifted injury concentrations to the extremities, as up to 80% of surviving 
combat-injured personnel sustain extremity injuries.4–6 These advances in personal 
body armor, coupled with improved vehicular armor, rapid aero-medical evacuation of 
casualties, and the deployment far-forward of cutting-edge medical technologies and 
treatments have improved the survival of wounded service   members. Likewise, similar 
emergency medical service and technological advances have improved   treatment of 
civilian casualties.7Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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The cumulative result of these technological advances is an 
unprecedented cohort of surviving casualties with   devastating 
war wounds, traumatic amputations, and   penetrating and 
closed traumatic brain injuries. These   high-energy blast 
wounds are characterized by massive zones of injury that 
combine bone, muscle, and soft tissue loss with gross bac-
terial and retained metal and composite material wound 
contamination.8–10 Patient management consists of rapid ini-
tial stabilization in the theater of operations,   inter-continental 
aero-medical evacuation, and multiple   surgical debridement 
procedures every 24–48 hours at   combat casualty care 
waypoints. A majority of injured   service members   present 
to definitive treatment facilities, such as Walter Reed Army 
Medical Center and National Naval Medical Center within the 
continental United States, with multiple complex wounds and 
a profound, ongoing systemic inflammatory response. These 
patients require additional diagnostic and serial   therapeutic 
interventions, including continued surgical   debridement 
procedures, which results in a prolonged hospital stay and 
long-term rehabilitation, amounting to resource-intensive 
protracted health care.
A considerable amount of time and resources is   committed 
to the care of this highly complicated patient   population. 
Unfortunately, patient-specific estimates of resource alloca-
tion, critical care utilization, length of hospital stay (LOS), 
nosocomial morbidity, and individual wound outcomes are dif-
ficult to create, or do not exist. Blast injuries pose   formidable 
therapeutic challenges, and occur in the context of multiple 
local and systemic impediments to healing,   making improv-
ing health care quality and outcomes extremely   challenging. 
These include systemic and local inflammation, as evidenced 
by measurable cytokine and chemokine profiles, deficient 
nutritional status, variable wound debridement adequacy, and 
the often-compromised vascular status of the injured limb(s). 
Describing and projecting relational outcomes of these highly 
complex, interrelated, and   time-dependent variables have 
proven difficult in modern-day health care systems. Addition-
ally, no applicable prognostic model exists for this complex 
patient population.
Recently, there has been renewed interest in a   modeling 
technique used to evaluate complex relationships such as those 
that exist in the cohort described above. Bayesian   models 
have been demonstrated to be useful in determining injury 
severity,11,12 intensive care unit (ICU) mortality,13   operative 
risk,14 and surgical outcomes.15–18 As greater emphasis is 
placed on improving the efficiency and quality of health care, 
improved methods to facilitate understanding of key factors 
impacting patient outcomes are needed. We sought to   evaluate 
the use of Bayesian belief networks (BBNs) as a method for 
developing networks of associations between clinical factors 
influencing health care outcomes of particular interest. The use 
of the BBN model has clinical utility for estimating clinical 
outcomes, particularly with incomplete clinical data, unlike 
logistic regression methodology, which requires complete 
data sets for prognostic variables. The BBN is a graphical 
modeling methodology that presents associations in a hier-
archical, comprehensible, graphical structure through an 
interactive interface for querying the model at point-of-care. 
This allows health care providers and clinical researchers 
a straightforward method to estimate clinical outcomes of 
interest on an individualized patient basis. Importantly, the 
BBN provides insights for complex clinical situations, show-
ing how important factors interrelate to impact important 
health care-related outcomes. This understanding can assist 
clinicians in developing individualized, targeted therapeutic 
interventions. We chose to evaluate this method in a severely 
wounded health care, resource-intensive, blast-related injury 
population by training a BBN. The BBN model was validated 
using 10-fold cross-validation, and then compared to logistic 
regression models trained, in order to gain insights from the 
BBN model.
In this proof-of-principle study, we explore the utility of 
BBN model development to help expand our   understanding 
of how biomarkers and health care outcomes associate in 
a population of war-wounded service members enrolled 
in a prospective observational clinical trial, through the 
  development of a graph of variable associations. We trained 
a BBN to evaluate associations between hospital-acquired 
infection, ICU LOS, hospital LOS, impaired wound healing, 
serum biomarkers, and clinical data at the time of admis-
sion to a tertiary care military medical center. This model 
effectively provides a model of association and estimation 
of nosocomial morbidity, hospital resource utilization, and 
length of stay. As such, it may serve as the basis for further 
independent validation studies in diverse trauma patient 
populations, and the development of novel models for health 
care quality improvement in patient populations with trau-
matic wounds.
Methods
Study methodology
The institutional review board approved this prospective obser-
vational clinical trial in compliance with all applicable   Federal 
regulations governing the protection of human subjects. 
Study participants were recruited from wounded US service 
members evacuated from Iraq and Afghanistan. Informed Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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consent was obtained from each study subject, or legal medical 
  representative. Inclusion criteria for this study were defined as 
adult, active duty service members who sustained high-energy, 
penetrating (open) extremity injuries during combat operations 
abroad. Those with pre-morbid confounding inflammatory 
conditions, including immune deficiency and connective tissue 
disorders, or any medical illness requiring immunosuppressive 
therapy, were excluded a priori.
Demographic and injury-related data were collected 
  prospectively, including: gender and age; date, location and 
mechanism of wounding; requirement for blood transfusion 
and total units of packed red blood cells (PRBCs) transfused; 
injury severity score (ISS) and Acute Physiology and Chronic 
Health Evaluation II (APACHE II) scores; wound surface area 
and depth, associated major vascular injury to the affected 
  extremity; and type of wound closure or coverage; Glasgow 
Coma Scale (GCS) and concomitant traumatic brain injury 
(defined by a consulting subject matter expert [eg, neurosurgeon, 
  neurologist] in the setting of closed or penetrating intracranial 
injury resulting from an externally applied force); intensive 
care unit length of stay, need for mechanical ventilation and 
ventilator days; number of surgical wound debridements in 
the operating room and hospital length of stay; development 
of nosocomial infection during the index hospitalization and 
impaired wound healing, as defined below.
Surgical debridement, saline irrigation, and negative 
pressure therapy utilizing vacuum-assisted closure (VAC®; 
Kinetic Concepts, San Antonio, TX) were repeated every 48 
to 72 hours until surgical wound closure or coverage (flap or 
split-thickness skin graft) occurred according to the current 
institutional standards of practice and at the discretion of the 
attending surgeon.
Human biological specimen collection
Peripheral venous whole blood (8 mL) was collected in a 
  Red-Top Serum BD Vacutainer® (Becton Dickinson,   Franklin 
Lakes, NJ) prior to each surgical wound   debridement, 
and immediately fractionated for serum   collection using 
a   centrifuge (Thermo-Electron Corp, Waltham, MA) at 
2500 × g (4°C) for 10 minutes. Serum supernatant samples 
were   transferred to individually labeled Cryo-Loc™ 
  polypropylene tubes (Lake Charles Manufacturing, Lake 
Charles, LA) and flash-frozen in liquid nitrogen. All samples 
were stored at −70°C until analysis.
Serum inflammatory biomarker analysis
Serum was diluted twofold with Beadlyte® Human Serum 
Sample Diluent (Millipore Corp, Billerica, MA) and as 
  previously described, serum proteins of interest were 
  quantitated using a Beadlyte® Human 22-Plex Multi-Cytokine 
Detection System on the Luminex® 100 IS xMAP Bead Array 
Platform (Millipore Corp).11,22 Briefly, this system utilizes 
analyte-specific monoclonal antibodies covalently linked 
to uniquely fluorescent beads with subsequent fluorescent-
report of analyte binding. Twenty-two cytokines were quanti-
fied (pg/mL) according to manufacturer’s instructions.
Wound closure, follow-up, and outcomes
All wounds were examined daily following wound closure 
or coverage until suture removal. All patients were followed 
clinically for a minimum of 30 days. Impaired wound heal-
ing included delayed wound closure or subsequent wound 
dehiscence. Delayed wound closure was defined as definitive 
closure occurring two standard deviations outside of the mean 
normal wound closure time period, or $21 days after injury. 
Dehiscence was defined as spontaneous partial or complete 
disruption of the surgical wound after closure or .50% graft 
loss, necessitating a return to the operating room for treat-
ment. Wounds that progressed to healing at 30 days following 
closure, without necessitating a return to the operating room, 
were considered healed. Hospital length of stay was defined 
from time of admission to the tertiary care Military Treatment 
Facility to the time of discharge from the same. Intensive care 
unit length of stay was calculated from time of admission to 
the ICU until time of transfer out of the ICU. Nosocomial 
infection was defined as an infection that was a result of 
treatment in hospital, but secondary to the patient’s original 
condition, that appeared 48 hours or more after admission or 
within 30 days of hospital discharge. Any culture-positive 
infection that, based on symptoms,   clinical, or radiological 
signs, required antibiotic therapy in the opinion of an Infec-
tious Disease physician was considered nosocomial.
Statistical analysis
Development of a Bayesian model 
to estimate outcome in war wounded
Data analysis was conducted using a BBN model. As a data 
modeling tool, BBNs have unique value in that they provide 
the user with a graphical representation of how variables 
associate to estimate outcomes. Multivariate dependence 
relationships between clinical variables, serum inflammation-
related biomarkers measured at time of study enrollment, and 
outcomes (nosocomial infection, ICU LOS, and impaired 
wound healing) were identified using FasterAnalytics™ 
Bayesian modeling software (DecisionQ, Washington, DC). 
This Bayesian modeling software uses   machine-learning Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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algorithms to dynamically detect complex patterns in 
multidimensional data sets. The BBN model   provided dem-
onstrates how multiple clinical variables   associate when 
estimating outcomes. The BBN modeling software supports 
a step-wise process in order to develop a robust model, 
consisting of an iterative process of training, qualitative and 
quantitative evaluation, parameter tuning, attribute pruning, 
and re-training. Tenfold intra-set cross-validation was per-
formed, to assess robustness of the final model, by training a 
BBN model on each of ten randomly-created, nonoverlapping 
training sets, each of which was used to create a set of case-
specific estimates, and each of which is characterized by a 
receiver operating characteristics curve to establish Bayesian 
classification accuracy.18–20
The 10-fold cross validation method is an established 
approach that provides reliable estimates of model accuracy. 
BBN models were trained both with and without biomarker 
data to assess the relative contribution of biomarkers to cur-
rent clinical data.
Development of logistic regression 
models to estimate outcome in war 
wounded
Forward stepwise logistic regression was also used to model 
estimates of impaired wound healing, ICU admission and 
occurrence of infection to assess whether the findings of 
the BBN would continue to be robust if transferred into 
another modeling methodology. Stepwise regression was 
chosen in the absence of an a priori rationale for ordering 
entry of predictor variables into the model, and is considered 
exploratory. Forward stepwise entry uses a likelihood ratio 
test (chi-square difference), based on maximum likelihood 
estimation, in order to determine which variables to retain 
in the model. It determines the forward entry model and 
then alternates between backward elimination and forward 
entry until all variables not in the model fail to meet entry or 
removal criteria. On the first step of each equation, selected 
clinical variables, determined by the Bayesian analysis, were 
entered: impaired wound healing was regressed on ICU 
admission; ICU admission was regressed on PRBCs and the 
APACHE II score; the occurrence of infection was regressed 
on PRBCs, the APACHE II score and ISS. In the second step 
of each equation, four biomarkers were entered: IL-6, IL-8, 
IL-12 p40, and MCP1, in order to assess the contribution of 
biomarkers to predictive power. Incomplete records were cen-
sored, as logistic regression analysis does not support model-
ing with incomplete information. The robustness of the LR 
models was assessed using 10-fold intra-set   cross-validation 
and receiver operating   characteristics (ROC) curve analysis, 
wherein the Area Under the Curve (AUC) for each of the 
models, with and without biomarkers, was compared to 
assess the improvement (curve lift) in the AUC curve from the 
addition of serum biomarkers. As the   Bayesian analysis was 
used for variable selection in the logistic regression analysis, 
the regression analysis was conducted to determine if the 
findings of the BBN analysis would continue to be robust in 
other modeling methodologies.
Results
Patient and wound characteristics
Thirty-two patients were enrolled in the study; all were 
males (age 19 to 42 years) with predominantly severe blast-
related injuries of war (Table 1). Sixty percent of patients 
required blood products for initial resuscitation (median 2, 
range 1–134 units PRBCs), and 40% required ICU admis-
sion for an average of 6 days per patient. Mean hospital 
LOS was one month (range 11–117 days), over which time 
an average of 6 surgical wound interventions were required 
until definitive wound closure or coverage. Nosocomial 
Table 1 Patient (wound) demographics
Category n = % Mean ± SD
Male 32 100.0%  
Age (years)     24.0 ± 5.9
Mechanism of injury      
Blast 21 65.6%  
Blast and blunt trauma 6 18.8%  
gunshot wound 4 12.5%  
Fall from height 1 3.1%  
Injury severity      
gcS     14.0 ± 2.3
iSS     15.0 ± 9.7
APAcHe     6.4 ± 5.2
icU admission 13 40.6%  
Mechanical ventilation 5 15.6%  
Transfusion      
initial PrBc transfusion     10.1 ± 24.3
initial PrBc # 4 units 11 34.4%  
initial PrBc . 4 units 21 65.6%  
Surgical interventions     6.0 ± 6.2
Length of stay (days)      
On ventilator     2.5 ± 6.8
icU     5.6 ± 14.5
Hospital     31.0 ± 23.6
Outcomes      
Any infection 14 43.8%  
impaired wound healing 6 18.8%  
Mortality 1 3.1%  
Abbreviations: gcS, glasgow coma Scale; iSS, injury severity score; APAcHe, 
acute physiology and chronic health evaluation; icU, intensive care unit; PcrB, 
packed red blood cells.Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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infections occurred in 44%, and impaired wound healing in 
19% of patients. Mean ISS and APACHE II scores at time 
of admission were 15.0 ± 9.7 (range: 4–36), and 6.4 ± 5.2 
(range: 1–22) respectively.
Development of BBn and Lr models  
to estimate outcome in war wounded
Figure 1 depicts the structure of the BBN network   developed 
to estimate likelihood of nosocomial infection (Infection Cat), 
requirement for ICU care (ICU Admit Cat), and impaired 
wound healing (Impaired Wound Healing Cat) without the use 
of serum biomarkers. This figure not only shows that there are 
extensive associations between outcomes and between clini-
cal variables and outcomes, but also allows us to understand 
how these different variables associate when estimating out-
comes, allowing us to develop hypotheses about mechanisms 
that can support clinical intervention. Figure 1 is a directed 
acyclic graph, wherein the arcs (lines) represent conditional 
dependence associations between otherwise independent 
factors. Thus, likelihood of nosocomial infection can be 
estimated a priori using serum albumin, injury severity score 
(ISS), and initial transfusion requirement; impaired wound 
healing can be estimated a priori using ICU admission; and 
likelihood of ICU admission can be estimated using initial 
transfusion requirement and APACHE II score. Figures 2–5 
shows the revised model, including serum biomarker data. 
The structure of the network in Figure 2 shows that likelihood 
of nosocomial infection can be estimated by ISS and initial 
transfusion requirement. Likelihood of ICU   admission can be 
estimated using initial transfusion requirement, APACHE II 
score, and serum IL-6. Finally, impaired wound healing can 
be estimated a priori using ICU admission, serum IL-8, and 
MCP-1 through   estimated hospital LOS.
Table 2 details the ten-fold cross-validation results from 
each train-and-test pair for the summarized posterior prob-
ability estimates of nosocomial infection, ICU admission, and 
impaired wound healing for both the BBN and LR Models. 
Both the trained BBN models and LR models are robust, 
with and without serum biomarkers, with ROC AUCs rang-
ing from 0.72 to 0.97. The table shows, for example, that the 
LR model can estimate nosocomial infection with an AUC of 
0.81, both with and without biomarkers, while the addition 
of biomarkers improves the AUC of the BBN model from 
0.76 to 0.79. Sensitivity and specificity statistics for LR and 
BBN models also show promise, with the ability to detect 
83% of impaired healing wounds with 67% specificity using 
the BBN with biomarkers, while the same BBN can detect 
93% of nosocomial infections with 63% specificity. These 
performance characteristics are consistent with many current 
clinical diagnostic tests, and with a larger sample size, there 
is opportunity for further improvement. The BBN receiver 
operating characteristics curve lift column calculates the 
improvement (or degradation) of performance statistics of 
the BBN compared to the LR models, while the biomarker 
lift column does the same calculation to evaluate the addi-
tion of serum biomarkers. The results for both methods 
are robust and remarkably similar. However, each method 
and feature set can be shown to outperform in a specific 
area. Importantly, one element that was missing from the 
cross-validation results was the assessment of the impact of 
partial information on robustness. Often, decisions are made 
on partial (incomplete or inaccurate) clinical information, 
ISS
Infection cat Initial RBC
HLOS
Impaired wound healing cat
ICU admit cat
Apache Albumin
Figure 1 Bayesian belief network of outcomes in war wounded, excluding biomarker data. The network demonstrates the hierarchical structure of the conditional 
dependence relationships between clinical parameter study variables.Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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and our decision support algorithms must incorporate this 
level of uncertainty. Logistic regression models cannot be 
calculated using partial records. Hence, LR models produce 
positively biased results. Conversely, BBN are designed to 
reflect uncertainty. Therefore, they can be trained on partial 
records, producing a negatively biased result. The cross-
validation statistics for the BBN models developed in this 
study reflect the inclusion of partial information, while the 
cross-validation statistics of the LR models do not. In order 
to assess the potential impact of partial information in the 
clinical setting, we used the nine records censored from the 
LR modeling (missing serum albumin results [n = 3], and 
missing results of some of the serum biomarkers [incomplete 
data set in 6 patients]) to perform independent set validation 
Table 2 Summary of 10-fold intra-set cross-validation exercises describing area-under-the-curve, sensitivity, specificity, accuracy, 
negative, and positive predictive values for key study outcomes. The first two column groups describe the performance of each of the 
BBn and Lr models, with and without biomarkers. The BBn Lift column group describes the lift, in points, of the BBn model compared 
to the Lr model in each test category, both excluding and including biomarkers, while the Biomarker Lift column group describes the 
lift of adding biomarker data to both the Lr and BBn models. Degradations in performance are described in parentheses
Without biomarkers With biomarkers BBN lift Biomarkers lift
LR BBN LR BBN Without With LR BBN
Impaired wound healing
AUc 0.91 0.79 0.91 0.72 (0.12) (0.19) 0.00 (0.07)
Percent correct 85.7% 76.7% 85.7% 70.0% (0.09) (0.16) 0.00 (0.07)
Positive predictive value 100.0% 40.0% 100.0% 38.5% (0.60) (0.62) 0.00 (0.02)
negative predictive value 81.0% 95.0% 81.0% 94.1% 0.14 0.13 0.00 (0.01)
Sensitivity 61.0% 80.0% 62.0% 83.3% 0.19 0.21 0.01 0.03
Specificity 100.0% 76.0% 100.0% 66.7% (0.24) (0.33) 0.00 (0.09)
ICU admission
AUc 0.97 0.76 0.97 0.81 (0.21) (0.16) 0.00 0.05
Percent correct 93.0% 80.0% 95.0% 80.0% (0.13) (0.15) 0.02 0.00
Positive predictive value 87.0% 72.7% 91.0% 72.7% (0.14) (0.18) 0.04 0.00
negative predictive value 99.0% 84.2% 97.0% 84.2% (0.15) (0.13) (0.02) 0.00
Sensitivity 98.0% 72.7% 95.0% 72.7% (0.25) (0.22) (0.03) 0.00
Specificity 93.0% 84.2% 95.0% 84.2% (0.09) (0.11) 0.02 0.00
Nosocomial infection
AUc 0.81 0.76 0.81 0.79 (0.05) (0.02) 0.00 0.03
Percent correct 73.0% 70.0% 73.0% 76.7% (0.03) 0.04 0.00 0.07
Positive predictive value 55.0% 75.0% 55.0% 68.4% 0.20 0.13 0.00 (0.07)
negative predictive value 84.0% 68.2% 84.0% 90.9% (0.16) 0.07 0.00 0.23
Sensitivity 67.0% 53.8% 67.0% 92.9% (0.13) 0.26 0.00 0.39
Specificity 75.0% 88.2% 75.0% 62.5% 0.13 (0.13) 0.00 (0.26)
Abbreviations: BBn, Bayesian belief network; Lr, logistic regression; AUc, area under the curve; icU, intensive care unit.
MCP-1_S HLOS Impaired wound healing cat
IL-8_S
IL-10_S
Apache
ICU admit cat
IL-6_S
Initial RBC
Infection cat
ISS
Albumin
Figure 2 Bayesian belief network of outcomes in war wounded, including biomarker data.Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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on the LR models. When we conducted this independent set 
validation on the LR models, the percent correct for impaired 
wound healing dropped from 86% to 78%, ICU   admission 
from 95% to 56%, and ability to estimate nosocomial 
  infection from 73% to 44%.
BBN models may be useful at the point of clinical care. 
This point is illustrated in Table 3, which represents an infer-
ence table calculated using the BBN model developed in this 
study. It shows how knowing ICU admission requirement (Yes 
or No), and the serum MCP-1 (pg/mL), and IL-8 (pg/mL) 
concentrations for an individual patient allows one to estimate 
case-specific likelihood of wound healing.
Discussion
The current conflicts in Iraq and Afghanistan have produced 
a patient population with multiple traumatic injuries for 
which definitive treatment requires the mobilization of large 
amounts of health care system resources to support protracted 
multidisciplinary care. We have previously determined that 
the systemic inflammatory response to injury in these patients 
can be measured and is related to subsequent outcomes such 
as wound failure, the development of heterotopic ossification, 
and the need for blood transfusions.21,22 However, we still lack 
a clear understanding of how health care outcomes and qual-
ity factors are related to one another, and how biomarkers can 
help us to better understand these quality indicators. We have 
developed a robust BBN model based on these   observations 
using machine-learned BBNs, and then validated these find-
ings through both cross-validation and further analysis with 
additional, previously nonexistent logistic regression mod-
els. By analyzing both clinical   variables and serum protein 
measurements (biomarkers) with the BBN models, we have 
developed a series of robust graphical models that can be 
used not only to estimate individual risk of wound failure, 
hospital-acquired infection, and intensive care admission, 
but also to give us a better understanding of the associations 
between these   factors, from which we can begin to design 
changes in clinical practice directed at improving outcomes 
and quality.
While both methods (BBN and LR) produced robust 
statistical results using intra-set cross-validation testing, 
there are some subtle but critical differences. Cross-vali-
dation allows us to estimate model performance in novel 
populations and to develop robust estimates of how we 
would expect a model to perform in a de novo population. 
Estimates of sensitivity, specificity, and positive and nega-
tive predictive values are consistent with the performance 
of many current clinical chemistry tests. With a larger study 
population and additional modeling, further improvements 
and optimization should be achievable. First, the selection 
of covariates was accomplished for both methods using the 
machine-learned BBN. The reason for this is that our initial 
Table 3 inference table calculated using the Bayesian model developed in this study for selected cases of icU admission, serum McP-1, 
and iL-8 concentrations
Probability of case  Independent variables Dependent variable
ICU admit cat  IL-8_S  MCP-1_S  Impaired wound healing cat 
No  Yes 
17.396%  no Up to 17.9 Up to 38.6 98.0  2.0 
7.721%  Yes Up to 17.9 Up to 38.6 74.0  26.0 
3.496%  no 17.9 to 19.6 Up to 38.6 97.5  2.5 
1.644%  Yes 17.9 to 19.6 Up to 38.6 69.4  30.6 
1.399%  no 19.6 plus Up to 38.6 81.2  18.8 
1.889%  Yes 19.6 plus Up to 38.6 20.1  79.9 
16.416%  no Up to 17.9 38.6 to 72.4 96.7  3.3 
8.394%  Yes Up to 17.9 38.6 to 72.4 63.4  36.6 
3.31%  no 17.9 to 19.6 38.6 to 72.4 96.0  4.0 
1.832%  Yes 17.9 to 19.6 38.6 to 72.4 58.1  41.9 
1.46%  no 19.6 plus 38.6 to 72.4 72.5  27.5 
2.66%  Yes 19.6 plus 38.6 to 72.4 13.3  86.7 
14.896%  no Up to 17.9 72.4 plus 95.9  4.1 
8.285%  Yes Up to 17.9 72.4 plus 57.8  42.2 
3.009%  no 17.9 to 19.6 72.4 plus 94.9  5.1 
1.831%  Yes 17.9 to 19.6 72.4 plus 52.2  47.8 
1.409%  no 19.6 plus 72.4 plus 67.6  32.4 
2.943%  Yes 19.6 plus 72.4 plus 10.8  89.2 Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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data set included clinical data as well as a 22-cytokine/
chemokine panel,   resulting in complex multivariate associa-
tions that are extremely difficult to assess and characterize 
using classical frequentist   statistical approaches. Further, 
the BBN   methodology incorporates all data elements into a 
single hierarchical graphical network, while the LR models 
are trained individually for each outcome of interest using a 
  linear construct. While this difference in method allows the 
LR models to more closely fit the data, producing better cross-
validation statistics in most cases, this most likely comes at 
the cost of reduced robustness, as shown when accuracy is 
assessed using clinical records with only partial informa-
tion, where the accuracy statistic degrades from 85.7% to 
77.8% in impaired wound healing, 95.0% to 55.6% in ICU 
admission, and 73.0% to 44.4% in infection. By comparison, 
all of the cross-validation statistics for the BBN models 
are inclusive of missing information. We further assessed 
the robustness of the LR models using partial information 
records that were censored in the LR model training but 
were included in the BBN model training. When this analy-
sis was performed, the accuracy statistics of the LR models 
degraded significantly, suggesting that the LR results may 
be positively biased by method, and may not be as robust as 
indicated when applied to actual (incomplete) clinical data. 
One of the critical differences between the BBN and LR 
methods, and the reason why BBNs can incorporate partial 
information without degraded robustness, is that the BBN is a 
nonlinear parametric classification method that demonstrates 
multivariate relationships between attributes that inform 
each other. LR is a linear classification method which does 
not allow for features to inform one another. Hence, partial 
information significantly degrades the   robustness of the LR 
methodology.
The critical improvement of using a graphical   modeling 
methodology such as the BBN method is its ability to 
  present associations in a hierarchical, user-friendly graphi-
cal   structure with an interactive interface for querying the 
model at point-of-care (Figure 1). This allows clinicians 
and researchers to not only arrive at posterior estimates of 
outcomes of interest while applying the model to individual 
patients, but also to begin to develop a better understanding of 
how factors combine to create important health care-related 
outcomes, which in turn allows the clinician to develop novel, 
targeted interventions. A clinician can enter patient-specific 
observations (evidence) into the model to derive estimates 
of hospital-acquired infection, requirement for intensive 
care, and likelihood of uncomplicated wound healing. This 
then permits clinicians to anticipate or estimate an outcome 
or complication of interest and intervene accordingly in a 
timely and cost-effective manner. For example, using the 
BBN, a patient with no prior transfusion requirement and an 
ISS # 9 has a low (7%) likelihood of nosocomial infection 
(Figure 3). If the same patient required four or more units 
of blood transfusions, the likelihood of hospital-acquired 
infection increases dramatically to 58% (Figure 4). This 
same patient’s information can simultaneously be utilized 
to calculate estimates of need for critical care (ICU admis-
sion, which is increased from 13% to 71%) and likelihood 
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of adverse wound healing outcome (risk of wound failure 
increased from 10% to 34%; Figure 5).
The results of this study are promising. Tenfold cross-
validation indicated that our BBN model is indeed robust, 
as measured by the receiver operating characteristics AUCs 
ranging from 0.72–0.81, and these results were re-affirmed 
by step-wise LR modeling using features identified by the 
BBN, which produce AUCs ranging from 0.81 to 0.97. 
Expanding the scope of this study is warranted to further 
assess model robustness, and to determine whether or not 
this model can improve clinical practice and patient outcomes 
in widespread application. Further study of additional data 
features may also improve the model, not only in terms of 
its robustness but also in terms of its clinical utility. The 
potential clinical utility of our model is demonstrated in 
that physicians applying ICU admission information, serum 
MCP-1, and IL-8 concentrations can develop case-specific 
estimates of resource-intensive wound care due to impaired 
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wound healing (Table 3). Further, the clinician can query the 
graphical user interface to understand why the estimate of 
outcome is being derived the way it is and what patient- and 
health care-related factors might be influenced to change it. 
One of the strengths of the methodology pilot-tested in this 
study is that it accounts for dimensionality and uncertainty 
and has the ability to codify complex clinical problems into 
straightforward, intuitive, robust classification models. For 
example, our simple pilot model has 729 distinct rule sets 
that can be applied using a priori information and statistically 
significant associations. These types of complex rule sets are 
difficult to translate into user-friendly systems. However, the 
BBN model interface allows the user to input clinical and 
laboratory data into a complex statistical model in a graphi-
cal, “user friendly” output (Figures 2–5).
While our early work is promising, our current model has 
distinct limitations given the complexity of our data. First, this 
model was developed using a limited patient population for 
the purposes of this pilot proof-of-concept study. While our 
cross-validation demonstrated that the model is robust, there is 
expected variance between testing exercises due to this small 
sample size. In order to reduce this variance, population sample 
size expansion is indicated to further refine our BBN model. 
Second, while our current model shows promising receiver 
operating characteristics for health care outcomes that are 
reasonable, further improvement is warranted. Finally, while 
the biomarkers studied were not additive, they were indeed 
illustrative of the utility of the modeling process applied in this 
study. These limitations aside, we believe that this approach 
outlines a significant step forward in the care of severely 
wounded casualties requiring complex multidisciplinary, 
resource-intensive care, with possible application far beyond 
the military population, in better understanding health care 
outcomes and quality. When compared with conventional, 
frequentist statistics, the BBN-defined model was equivalent 
and demonstrated increased robustness when missing vari-
ables (often encountered in clinical practice) were evaluated. 
Further, this approach was able to define relationships not 
readily apparent with standard methods, and to codify them 
into a graphical interface that allows the clinician to understand 
how patterns of association relate to outcomes and quality on a 
patient-specific basis. This ability to analyze complex datasets 
consisting of clinical data, standard laboratory values, and 
molecular biomarkers in an inter-dependent fashion represents 
a meaningful advance in our toolset for improving health care 
quality and outcomes. Demonstrating the ability to estimate 
outcomes is the first step among many towards individualized 
care, as models such as these are coupled to medical treatment 
interventions. Using a combat-wounded population, we have 
demonstrated the potential of such an approach, that warrants 
expansion into a larger, broader trial, as well as to other aspects 
of medical and surgical care.
Conclusion
We developed a BBN model utilizing numerous clinical 
factors and biomarkers. This integrated proof-of-principle 
model is robust in estimating clinical   outcomes in patients 
hospitalized with combat wounds, as determined through 
cross-validation. We further   re-affirmed our findings with 
additional cross-validated logistic   regression modeling, 
trained using insights developed from the BBN. We chose a 
homogeneous study cohort to limit the number of confound-
ing variables in this pilot study. The model, in its current 
form, is not generalizable to a broad trauma population. 
From this initial development of a BBN for the estimation 
of clinically relevant outcomes, we intend to expand the 
study to a larger trauma population, and introduce addi-
tional variables in a step-wise manner in order to make 
the model applicable to a wide-ranging trauma population. 
The methods developed in this study have the potential 
to fundamentally change the quality of health care by 
empowering the clinician to reason uncertainty in complex 
high-dimensionality datasets, and reduce the information 
into usable and personalized networks of associations that 
allow the clinician to both better understand those factors 
influencing outcome as well as to estimate the likelihood of 
a case-specific outcome.
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